16
Participants
Start Date
November 10, 2022
Primary Completion Date
May 31, 2026
Study Completion Date
September 30, 2026
Baricitinib
Oral tablets (2 mg) will be used For children \> or = 6 years: 4 mg once a day (2 x 2 mg) during the 24 weeks-period study For children \< 6 years: 2 mg once a day during the 24 weeks -period study
pharmacokinetics study
additionnal blood sampling at week 4, 8, 12, and 24
dosage of cytokines
additionnal blood sampling at weeks 0, 4 and 24
transcriptomic analysis
additionnal blood sampling at weeks 0, 4 and 24
Parent version of the Child Health Questionnaire (CHQ)
Evaluate by parents at each visits
Childhood Health Assessment Questionnaire
Evaluate by parents at each visits
Pregnancy test
Urine pregnancy test at V4 A dosage of bHCG with current biological analysis is done at each visit (except V4)
RECRUITING
Hôpital Pellegrin, Bordeaux
RECRUITING
Hôpital Femme Mère Enfant, Bron
RECRUITING
Hôpital Jeanne de Flandre, Lille
RECRUITING
Hôpital La Timone, Marseille
NOT_YET_RECRUITING
Hôpital Villeneuce, Montpellier
RECRUITING
Hôpital Brabois, Nancy
RECRUITING
Hopital Necker - Enfants malades : unité d'immuno-hématologie et rhumatologie, Paris
RECRUITING
Hôpital du Kremlin-Bicêtre, Paris
RECRUITING
Hôpital Necker - Enfants malades : service de dermatologie, Paris
RECRUITING
Hôpital Robert Debré, Paris
RECRUITING
Hôpital Trousseau, Paris
NOT_YET_RECRUITING
Hôpital de Hautepierre, Strasbourg
RECRUITING
Hôpital Purpan, Toulouse
Assistance Publique - Hôpitaux de Paris
OTHER